NCT06302335

Povidone-iodine vs Saline Solution in Colorectal Surgeries and Its Effects on the Surgical Site Infection

Name: Clinical Trial NCT06302335
Creator: Hospital de Clinicas de Porto Alegre
Keywords: Surgical Site Infection, Povidone-iodine, Phase 3, drug, clinical trial, Brazil

Intraoperative Irrigation of the Surgical Incision With Povidone-iodine vs Saline Solution in Colorectal Surgeries and Its Effects on the Surgical Site Infection

Hospital de Clinicas de Porto Alegre·Phase 3·ClinicalTrials.gov·drugRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Surgical Site Infection
Drug/Device/Intervention: Povidone-iodine
Study type: Interventional
Intervention type: drug

Sponsor & location

Primary sponsor: Hospital de Clinicas de Porto Alegre
Location: Porto Alegre, Brazil

Timeline & enrollment

Phase: Phase 3
Start date: Jan 02, 2023
End date: Dec 31, 2027
Enrollment: 228 participants

Primary outcome

Surgical site infection

Summary

Considering the relatively high incidence of surgical site infection (SSI) in colorectal surgery, this trial will compare rates of SSI in patients undergoing colorectal resections followed by surgical wound irrigation with povidone-iodine versus the group of patients undergoing surgical wound irrigation with saline solution. The trial will be conducted in a large university hospital in Southern Brazil.

ICD-10 classifications

Infection following a procedure, not elsewhere classifiedBacterial infection of unspecified siteOther bacterial infections of unspecified siteInfection of obstetric surgical woundOther specified local infections of skin and subcutaneous tissue

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06302335
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06302335 through Pure Global AI's free database. This Phase 3 trial is sponsored by Hospital de Clinicas de Porto Alegre and is currently Recruiting. The study focuses on Surgical Site Infection. Target enrollment is 228 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.